ThomasWardGriffinMD

Radiation Oncology • Seattle, WA

Physician

Join to view full profile

Are you Dr. Griffin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 12 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
3620 E Prospect St

Seattle, WA 98112
Phone+1 206-322-6742

Fax+1 206-322-6803
Is this information wrong?

Summary

Dr. Thomas Griffin, MD is a radiation oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington, New Jersey, and California.

Education & Training

Weill Cornell MedicineClass of 1972

Certifications & Licensure

WA State Medical License 1973 - 2025
AZ State Medical License 1973 - 2019
CA State Medical License 1978 - 2018
NJ State Medical License 1996 - 2017
American Board of Radiology Therapeutic Radiology

Publications & Presentations

PubMed

15 citations
Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer
Xu Steven Xu, Charles J. Ryan, Kim Stuyckens, Matthew R. Smith, Fred Saad, Thomas W. Griffin, Youn C. Park, Margaret K. Yu, Peter De Porre, An Vermeulen, Italo Poggesi...> ;Clinical Pharmacokinetics. 2017 Jan 1
14 citations
Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.
Weimin Li, Joyce O'Shaughnessy, Daniel F. Hayes, Mario Campone, Igor Bondarenko, Irina Zbarskaya, Etienne Brain, Marina Stenina, Olga Ivanova, Marie-Pascale Graas, Pat...> ;Clinical Cancer Research. 2016 Dec 15
22 citations
Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Stu...
Joaquim Bellmunt, Thian Kheoh, Margaret K. Yu, Matthew R. Smith, Eric J. Small, Peter F.A. Mulders, Karim Fizazi, Dana E. Rathkopf, Fred Saad, Howard I. Scher, Mary-El...> ;European Urology. 2016 May 1
34 citations
Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis o...
Karim Fizazi, Thomas W. Flaig, Michael Stöckle, Howard I. Scher, J.S. de Bono, Dana E. Rathkopf, Charles J. Ryan, Thian Kheoh, Jinhui Li, Mary B. Todd, Thomas W. Griff...> ;Annals of Oncology. 2016 Apr 1
50 citations
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer
Joyce O'Shaughnessy, M. Campone, Etienne Brain, Patrick Neven, Daniel F. Hayes, Igor Bondarenko, Thomas W. Griffin, Joost Martin, P. De Porre, Thian Kheoh, Margaret K....> ;Annals of Oncology. 2016 Jan 1
58 citations
Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer
Kim N. Chi, Jennifer L. Spratlin, Christian K. Kollmannsberger, Scott North, Catherine Pankras, Martha Gonzalez, Apexa Bernard, Hans Stieltjes, Lixian Peng, James Jiao...> ;Journal of Clinical Pharmacology. 2015 Dec 1
56 citations
Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer.
Matthew R. Smith, Dana E. Rathkopf, Peter F.A. Mulders, Joan Carles, Hendrik Van Poppel, Jinhui Li, Thian Kheoh, Thomas W. Griffin, Arturo Molina, Charles J. Ryan> ;The Journal of Urology. 2015 Nov 1
110 citations
Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results
Michael J. Morris, Arturo Molina, Eric J. Small, Johann S. de Bono, Christopher J. Logothetis, Karim Fizazi, Paul de Souza, Philip W. Kantoff, Celestia S. Higano, Jinh...> ;Journal of Clinical Oncology. 2015 Apr 20
48 citations
Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiratero...
Gerhardt Attard, Johann S. de Bono, Christopher J. Logothetis, Karim Fizazi, Som D. Mukherjee, Anthony M. Joshua, D. Schrijvers, Alfons J.M. van den Eertwegh, Weimin L...> ;Clinical Cancer Research. 2015 Apr 1
48 citations
Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate-Treated Castration-Resistant Prostate Cancer Patients
Xu Steven Xu, Charles J. Ryan, Kim Stuyckens, Matthew R. Smith, Fred Saad, Thomas W. Griffin, Youn C. Park, Margaret K. Yu, An Vermeulen, Italo Poggesi, Partha Nandy> ;Clinical Cancer Research. 2015 Mar 31
900 citations
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final o...
Charles J. Ryan, Matthew R. Smith, Karim Fizazi, Fred Saad, Peter F.A. Mulders, Cora N. Sternberg, Kurt Miller, Christopher J. Logothetis, Neal D. Shore, Eric J. Small...> ;The Lancet. Oncology. 2015 Feb 1
192 citations
Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (C...
Dana E. Rathkopf, Matthew R. Smith, Johann S. de Bono, Christopher J. Logothetis, Neal D. Shore, Paul de Souza, Karim Fizazi, Peter F.A. Mulders, Paul N. Mainwaring, J...> ;European Urology. 2014 Nov 1
32 citations
Response to Subsequent Docetaxel in a Patient Cohort With Metastatic Castration-Resistant Prostate Cancer After Abiraterone Acetate Treatment
Rahul Aggarwal, Anna Harris, Carl Formaker, Eric J. Small, Arturo Molina, Thomas W. Griffin, Charles J. Ryan> ;Clinical Genitourinary Cancer. 2014 Oct 1
37 citations
Population Pharmacokinetic Analysis of Abiraterone in Chemotherapy-Naïve and Docetaxel-Treated Patients with Metastatic Castration-Resistant Prostate Cancer
Kim Stuyckens, Fred Saad, Xu Steven Xu, Charles J. Ryan, Matthew R. Smith, Thomas W. Griffin, Margaret K. Yu, An Vermeulen, Partha Nandy, Italo Poggesi> ;Clinical Pharmacokinetics. 2014 Sep 10
122 citations
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome re...
Ethan Basch, Karen A. Autio, Charles J. Ryan, Peter F.A. Mulders, Neal D. Shore, Thian Kheoh, Karim Fizazi, Christopher J. Logothetis, Dana E. Rathkopf, Matthew R. Smi...> ;The Lancet. Oncology. 2013 Nov 1
48 citations
A phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects
Milin Acharya, Martha Gonzalez, Geert Mannens, Ronald de Vries, Christian Lopez, Thomas W. Griffin, Namphuong Tran> ;Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 2013 Mar 5
1961 citations
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, Arturo Molina, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Paul N. Mainwaring, Josep M. Piulats, Siob...> ;The New England Journal of Medicine. 2013 Jan 9
69 citations
Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups.
Martha Milanes-Yearsley, M. Elizabeth H. Hammond, Thomas F. Pajak, Jay S. Cooper, Chu Chang, Thomas W. Griffin, Diana F. Nelson, George E. Laramore, Milijenko Pilepich> ;Modern Pathology. 2002 Dec 1
113 citations
Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy.
James G. Douglas, George E. Laramore, M. Austin-Seymour, Wui Jin Koh, Keith J. Stelzer, Thomas W. Griffin> ;International Journal of Radiation Oncology, Biology, Physics. 2000 Feb 1
28 citations
Neutron radiotherapy for the treatment of locally advanced major salivary gland tumors
James G. Douglas, Shawn Lee, George E. Laramore, M. Austin-Seymour, Wui Jin Koh, Thomas W. Griffin> ;Head & Neck. 1999 May 1
101 citations
REDUCTION OF RADIOACTIVE SEED EMBOLIZATION TO THE LUNG FOLLOWING PROSTATE BRACHYTHERAPY
Elizabeth M Tapen, John C. Blasko, Peter D. Grimm, Haakon Ragde, Ray W. Luse, Stephanie Clifford, John Sylvester, Thomas W. Griffin> ;International Journal of Radiation Oncology, Biology, Physics. 1998 Dec 1
7 citations
Digital radiotherapy simulator
Pau S. Cho, Karen L. Lindsley, James G. Douglas, Keith J. Stelzer, Thomas W. Griffin> ;Computerized Medical Imaging and Graphics. 1998 Jan 1
7 citations
Fast Neutrons in Prostatic Adenocarcinomas: Worldwide Clinical Experience
K.L. Lindsley, Paul S. Cho, Keith J. Stelzer, Wui Jin Koh, M. Austin-Seymour, Kenneth J. Russell, George E. Laramore, Thomas W. Griffin> ;Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 1998 Jan 1
9 citations
Boron neutron capture enhanced fast neutron radiotherapy for malignant gliomas and other tumors
Thomas A. Buchholz, George E. Laramore, Keith J. Stelzer, Rudolf Risler, Peter Wootton, Thomas W. Griffin> ;Journal of Neuro-Oncology. 1997 May 1
32 citations
Corpus callosum involvement as a prognostic factor for patients with high-grade astrocytoma
Keith J. Stelzer, Kristen I. Sauvé, Alexander M. Spence, Thomas W. Griffin, Mitchel S. Berger> ;International Journal of Radiation Oncology, Biology, Physics. 1997 Apr 1
Join now to see all